Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib in Locally Advanced or Metastatic Chordoma
NCT03110744Phase 2Completed
- Sponsor
- Heidelberg University Hospital
- Start
- Dec 2017
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in chordoma, sponsored by Heidelberg University Hospital. Started Dec 2017; status: completed.
02
Drugs
palbociclib
03
Conditions
chordoma
Beyond the preview
Go deeper on NCT03110744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03110744.